A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.
Paltar Petroleum to be wound up after judge finds ‘too much uncertainty’ in DOCA
Aussie boot maker ordered to pay $450,000 for infringing Deckers’ UGG trade mark
La Trobe University academics can’t keep names secret in law school head’s legal action
Hutchinson Builders resolves case against ACCC over notice to produce
Private construction company Hutchinson Builders has resolved a lawsuit it brought against the Australian Competition and Consumer Commission seeking to quash what it called an invalid notice to produce documents to the regulator, which has vowed to bring cases against the construction industry this year.
Judge shoots down ASIC’s ‘amorphous’ request for inquiry into liquidators
Brambles shareholder class actions consolidated despite stalemate between firms
A judge has consolidated two shareholder class actions brought against chain logistics company Brambles by Slater & Gordon and Maurice Blackburn, despite the rival firms failing to reach an agreement on the terms of the consolidation following a judge’s criticism of the class action “beauty parade”.